Opthea presents Wet AMD data at Macula Society Meet
Opthea Limited (NASDAQ:OPT), a biopharmaceutical company with a market capitalization of $894.5 million specializing in the ...
70+ Key Companies Advancing in Dry Age-Related Macular Degeneration Clinical Trial ...
DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...